Events / Women in COG

1 Nov 2022

Women in COG: in Conversation with Dr Sam Barrell

On Tuesday 22nd November, at 12:15 – 13:00 GMT, we will be hosting our ‘Women in COG’ event featuring Dr Sam Barrell, the Deputy Chief Executive Officer of the Francis Crick Institute.

This event will feature a conversation with Sam followed by an informal Q&A.


When? 22nd November 12:15h
Where? Virtual
Who can attend? Everyone

Dr Sam Barrell 

Dr Sam Barrell is the Deputy Chief Executive Officer of the Crick and is responsible for leading the operational management and running of the institute. She joined the Crick in September 2017 from a career in the NHS as a noted healthcare leader. Sam was Chief Executive of the Taunton and Somerset NHS Foundation Trust. Before that, she was the Accountable Officer and led the formation of the South Devon and Torbay Clinical Commissioning Group. Sam was awarded the CBE in 2014 for services to healthcare.

COVID-19 Genomics UK (COG-UK)

The COVID-19 Genomics UK (COG-UK) consortium works in partnership to harness the power of SARS-CoV-2 genomics in the fight against COVID-19.

Led by Professor Sharon Peacock of the University of Cambridge, COG-UK is made up of an innovative collaboration of NHS organisations, the four public health agencies of the UK, the Wellcome Sanger Institute and sixteen academic partners. A full list of collaborators can be found here.

The COVID-19 pandemic, caused by SARS-CoV-2, represents a major threat to health. The COG-UK consortium was formed in March 2020 to deliver SARS-CoV-2 genome sequencing and analysis to inform public health policy and to support the establishment of a national pathogen sequencing service, with sequence data now predominantly generated by the Wellcome Sanger Institute and the Public Health Agencies.

SARS-CoV-2 genome sequencing and analysis plays a key role in the COVID-19 public health response by enabling the identification, tracking and analysis of variants of concern, and by informing the design of vaccines and therapeutics. COG-UK works collaboratively to deliver world-class research on pathogen sequencing and analysis, maximise the value of genomic data by ensuring fair access and data linkage, and provide a training programme to enable equity in global sequencing.